7 active not recruiting. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Active not recruiting 7 |
Follow Ischemia: new trials by email Literature Review of Ischemia trials Research Report on Ischemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) Pelacarsen (TQJ230) - Cardiovascular Disease and Lipoprotein(a) | Phase 3 | Active not recruiting | Novartis Pharmaceuticals | 5700 | 2026-05-11 | 2026-10-14 |
| Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus Vitamin K antagonist, Direct oral anticoagulant - Intracardiac Thrombus, STEMI | Phase 3 | Active not recruiting | Centre Hospitalier Universitaire de Nīmes | 340 | 2023-05-15 | 2026-02-17 |
| A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, Placebo in 1.5ml - Primary Prevention of Atherosclerotic Cardiovascular Disease | Phase 3 | Active not recruiting | Novartis Pharmaceuticals | 14012 | 2023-03-09 | 2026-11-05 |
| A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI zalunfiban, Placebo - ST-elevation Myocardial Infarction (STEMI) | Phase 3 | Active not recruiting | CeleCor Therapeutics | 2463 | 2021-04-24 | 2025-10-23 |
| Evolocumab in STEMI Repatha® - ST Elevation Myocardial Infarction | Phase 3 | Active not recruiting | Sejong General Hospital | 166 | 2020-12-05 | 2025-06-19 |
| Trial to Assess Chelation Therapy in Critical Limb Ischemia Edetate Disodium, Placebo - Critical Limb Ischemia, Diabetes | Phase 3 | Active not recruiting | Mt. Sinai Medical Center, Miami | 50 | 2019-03-19 | 2026-07-01 |
| Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention NAC, Saline - Acute ST Segment Elevation Myocardial Infarction | Phase 3 | Active not recruiting | Suleyman Demirel University | 100 | 2013-01-01 | 2025-05-20 |
ST Elevation Myocardial Infarction (4) · Stroke (3) · Cardiovascular Diseases (2) · Myocardial Infarction (2) · Acute Coronary Syndrome (1) · Chronic Limb-Threatening Ischemia (1) · Coronary Artery Disease (1) · Coronary Stenosis (1) · Diabetes Mellitus (1) · Dyslipidemias (1) · Embolism (1) · Heart Failure (1) · Hypercholesterolemia (1) · Hyperlipidemias (1)
Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Vascular Diseases (7) · Heart Diseases (6) · Infarction (6) · Myocardial Ischemia (6) · Necrosis (6) · Cardiovascular Diseases (5) · Myocardial Infarction (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Nervous System Diseases (3) · Arterial Occlusive Diseases (2)
ALN-PCS (1) · N(4)-oleylcytosine arabinoside (1) · Pentetic Acid (1) · Sodium Chloride (1) · acarboxyprothrombin (1) · evolocumab (1) · pelacarsen (1)
Novartis Pharmaceuticals (2) · CeleCor Therapeutics (1) · Centre Hospitalier Universitaire de Nīmes (1) · Mt. Sinai Medical Center, Miami (1) · Sejong General Hospital (1) · Suleyman Demirel University (1)
France (4) · United States (4) · Canada (3) · Czechia (3) · Hungary (3) · Mexico (3) · Netherlands (3) · Romania (3) · Turkey (Türkiye) (3) · Argentina (2) · Australia (2) · Austria (2) · Belgium (2) · Brazil (2) · Bulgaria (2)
PMID 36592878, PMID 41211981, PMID 41728285, PMID 42303064, PMID 42727626